Philip Badman

Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study

Adam N. Rosenthal, Lindsay Fraser, Susan Philpott et al. · Journal of Clinical Oncology · 2017 · 211 citations · Full text

Medicine, Gynecology, Oncology +16

Results of Annual Screening in Phase I of the United Kingdom Familial Ovarian Cancer Screening Study Highlight the Need for Strict Adherence to Screening Schedule

Adam N. Rosenthal, Lindsay Fraser, Ranjit Manchanda et al. · Journal of Clinical Oncology · 2012 · 148 citations · Full text

Medicine, Gynecology, Oncology +17

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer

R. Charles Coombes, Holly Tovey, Lucy Kilburn et al. · JAMA Oncology · 2021 · 47 citations · Full text

Medicine, Oncology, Pharmacology +15

RADICAL trial: A phase Ib/IIa study to assess the safety and efficacy of AZD4547 in combination with either anastrozole or letrozole in ER positive breast cancer patients progressing on these aromatase inhibitors (AIs).

Michael J. Seckl, Philip Badman, Xinxue Liu et al. · Journal of Clinical Oncology · 2017 · 17 citations

Medicine, Oncology, Pharmacology +15

Final results of 4-monthly screening in the UK Familial Ovarian Cancer Screening Study (UKFOCSS Phase 2).

Adam N. Rosenthal, Lindsay Fraser, Susan Philpott et al. · Journal of Clinical Oncology · 2013 · 15 citations

Medicine, Gynecology, Oncology +17